Chennai: More than 7,000 SARS-CoV-2 mutations have been documented but that doesn’t translate to variants, say, scientists, emphasising the distinction between the two and cautioning that the spike in cases in some states is likely due to non-adherence of Covid-19 appropriate behaviour.
If safety protocols are not followed, new versions that can spread faster or dominate the previous version could emerge, they warned as worries mounted over a recent study showing 7,684 mutations in the SARS-CoV-2 genome in India.
Though the study from Hyderabad’s CSIR-Centre for Cellular and Molecular Biology is alarming and led to panic in some quarters, some mutations are only to be expected.
According to Rakesh Mishra, CSIR-CCMB director and study co-author, 7,684 mutations in the SARS-CoV-2 genome were documented from the data analysis of 6,017 genomes sequenced so far.
“That doesn’t mean 7,000 variants are going around in the country. This only shows that the virus is mutating as expected, and we have documented what these mutations are,” Mishra said.
He added that it is difficult to say right now how many variants there are in the country.
A mutation means a change in a nucleic acid base or amino acid molecule, and a virus containing this change is termed a mutant, explained virologist Upasana Ray.
Mutations eventually accumulate to generate variants that differ from the original virus more and more, and so, a variant can have limited or even cumulative mutations, she added.
While it is not surprising to find many new mutations, it is important to sequence and document them, said the senior scientist at Kolkata’s CSIR-Indian Institute of Chemical Biology.
“Not all mutations would even linger around in the population for long. Some remain, some fade off,” Ray said.
The mutation is not unique to SARS-CoV-2, she said. The longer a virus stays in the population and spreads, the more the mutations and hence more variants.
“If a virus attains a significant degree of change from its original form so that there is a major change in antigenic epitopes, it has a chance to escape the immunity offered by the existing vaccines,” Ray said.
An epitope is the part of virus cells that is recognised by the immune system.
The analysis by CSIR-CCMB found that novel variants worrying many countries globally have so far only low prevalence in India. These include the variants with the immune-escape E484K mutation and the one with the N501Y mutation found to have a higher transmission rate. While the E484K mutation is found in both the South African and Brazil variant lineages, the N501Y mutation is found in the UK variant.
But the low prevalence in the country might be simply because not enough sequencing has been done, the authors of the study said, calling for robust sequencing of coronavirus genomes across India.
Noted virologist Shahid Jameel said there are currently 5,261 SARS-CoV-2 sequence entries from India in the GISAID database, a global science initiative that provides genomic data of the coronavirus responsible for the COVID-19 pandemic.
“With 11 million confirmed cases, that is a sequencing rate of under 0.05 per cent,” Jameel, director, Trivedi School of Biosciences, Ashoka University, said.
In his view, there isn’t enough information on mutations, especially variant lineages in India, due to low sequencing.
He, however, cautioned that it is important to understand that more transmission will increase the chances of mutations developing.
“So Covid appropriate behaviour also cuts down on the development of variant viruses,” he said.
Mishra agreed that the current surge in certain states is less likely due to some new variant, and more likely due to people ignoring Covid protocols.